Fulgent Genetics, Inc. (FLGT) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Fulgent Genetics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.874 Greetings and welcome to the Folger Genetics second quarter 2026 conference call and 00:00:04.874 -- 00:00:06.295 webcast. 00:00:06.295 -- 00:00:09.617 At this time, all participants are in listen-only mode. 00:00:09.617 -- 00:00:12.779 A question and answer session will follow the formal presentation. 00:00:12.779 -- 00:00:17.062 You may be placed into question queue at any time by pressing star 1 on your telephone 00:00:17.062 -- 00:00:18.863 keypad. 00:00:18.863 -- 00:00:21.845 As a reminder, this conference is being recorded. 00:00:21.845 -- 00:00:26.008 If anyone should require operator assistance, please press star 0. 00:00:26.008 -- 00:00:30.004 It's now my pleasure to turn the call over to Lauren Sloan, Investor Relations. 00:00:30.004 -- 00:00:32.445 Lauren, please go ahead. 00:00:32.445 -- 00:00:37.587 Good afternoon and welcome to Fulgent's second quarter 2026 financial results conference 00:00:37.587 -- 00:00:42.669 call. On the call are Ming Hsieh, Chief Executive Officer, Paul Kim, 00:00:42.669 -- 00:00:47.691 Chief Financial Officer, and Brandon Perthuis, Chief Commercial Officer. 00:00:47.691 -- 00:00:51.772 The company's press release discussing the financial results is available on the investor 00:00:51.772 -- 00:00:56.133 relations section of the company's website, ir.fulgentgenetics.com. 00:00:56.862 -- 00:01:00.805 A replay of this call will be available shortly after the call concludes on the investor 00:01:00.805 -- 00:01:03.888 relations section of the company's website. 00:01:03.888 -- 00:01:08.091 Management's prepared remarks and answers to your questions on today's call will contain 00:01:08.091 -- 00:01:13.156 forward-looking statements. These forward-looking statements represent management's estimates ...